PMA

P150024: AspireAssist

FDA PMA · Aspiration therapy system · Aspire Bariatrics, Inc.

Key facts

PMA number P150024
Trade name AspireAssist
Generic name Aspiration therapy system
Applicant Aspire Bariatrics, Inc.
Product code OYF
Approval date Jun 14, 2016
Docket number 16m-1754
Notice date Jun 14, 2016
FEI number 3009595931

At a glance

  • 10–99 Supplements
  • Apr 24, 2020 Latest supplement decision
  • Yes Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals